Gemzar and Pradaxa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gemzar (gemcitabine hydrochloride) and Pradaxa (dabigatran etexilate mesylate). Common drug interactions include pancytopenia among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Gemzar and Pradaxa. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Gemzar?

Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.

What is Pradaxa?

Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.

On Jul, 16, 2026

19 people who take Gemzar and Pradaxa together, and have interactions are studied.

What are the common drug interactions of Gemzar and Pradaxa, by gender? *:

female:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Anaemia (lack of blood)
Dehydration (dryness resulting from the removal of water)
Disease progression
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
General physical health deterioration (weak health status)
Haemorrhagic anaemia (anaemia due to excessive bleeding)
Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)
Mucosal inflammation (infection of mucous membrane)
Platelet count decreased

male:

Renal failure (kidney dysfunction)
Alanine aminotransferase increased
Cholecystitis (infection of gallbladder)
Duodenitis (inflammation of the duodenum)
Fatigue (feeling of tiredness)
Gastritis (inflammation of stomach)
Pain
Ascites (accumulation of fluid in the abdominal cavity)
Concomitant disease progression (progress in accompanying disease)
Encephalopathy (functioning of the brain is affected by some agent or condition)

What are the common drug interactions of Gemzar and Pradaxa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haemorrhagic anaemia (anaemia due to excessive bleeding)

60+:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Renal failure (kidney dysfunction)
Blood alkaline phosphatase increased
Blood bilirubin increased
Concomitant disease progression (progress in accompanying disease)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Gamma-glutamyltransferase increased
Haemobilia (presence of blood in the biliary tract)
Malignant neoplasm progression (cancer tumour came back)
Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)

What are the existing conditions these people have? *

High Blood Pressure: 5 people, 26.32%
Breast Cancer: 3 people, 15.79%
Abdominal Pain: 2 people, 10.53%
Diabetes: 2 people, 10.53%
Adenocarcinoma Pancreas (cancer of pancreas): 2 people, 10.53%
Pain: 2 people, 10.53%
Neuropathy Peripheral (surface nerve damage): 2 people, 10.53%
Nausea (feeling of having an urge to vomit): 2 people, 10.53%
Cardiac Disorder: 2 people, 10.53%
Cardiac Failure Chronic: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Gemzar and Pradaxa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously